PPT-DYSLIPIDEMIA IN DIABETES

Author : esther | Published Date : 2022-06-07

MAHTAB NIROOMAND MD Assistant professor of Endocrinology SBUMS Tehran 13911119 Outline Pathophysiology and types of dyslipidemia in diabetic patients Benefits

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "DYSLIPIDEMIA IN DIABETES" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

DYSLIPIDEMIA IN DIABETES: Transcript


MAHTAB NIROOMAND MD Assistant professor of Endocrinology SBUMS Tehran 13911119 Outline Pathophysiology and types of dyslipidemia in diabetic patients Benefits of lipid lowering therapy. diabetesorg Diabetes is one of the leading causes of disability and death in the United States If its not controlled diabetes can cause blindness nerve damage kidney disease and other health problems One in 12 Americans has diabetes thats more than .   . True . False . Question:1. Type 2 diabetes is often a silent disease. You may feel just fine even though chronically high blood sugar levels are doing serious damage to your body. When it comes to monitoring diabetes, don't rely on how you feel. Don't wait until it's advanced enough to cause symptoms.. http://www.vinafengshui.com/wp-content/uploads/2014. Presentation Purpose. To increase knowledge about identifying carbohydrates, carbohydrate counting, and portion sizes of carbohydrates. To understand the important role of the diet in diabetes. Michael Hunt, . Director, Health Spending and Strategic Initiatives. Canadian Institute for Health Information (CIHI). Shari . Dworkin. , Director, Canada Health . Infoway. SCWG Concurrent Session. November 26, 2013 8.30am. 2013 ACC/AHA Guideline on the. Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. IMPROVE-IT. 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia. Definition of Diabetes. Diabetes is a . disease in which the body does not . produce. or . properly use. the hormone . insulin.. 2. Take Charge of Your Diabetes, University of Florida IFAS Extension © 2010. In diabetes:. Body does not make or properly use insulin. Insulin is needed to:. Move glucose from blood into cells for energy. If insulin isn’t working, high blood glucose results:. Energy levels are low. Definition. Type 1 Diabetes. : This refers to a genetically based condition in which the cells in the pancreas that normally produce a hormone called “Insulin” stop functioning. This often appears in childhood or early adolescence. The only treatment for Type 1 Diabetes is insulin replacement (by pump or injection). Without adequate supplementary insulin, blood sugar levels dramatically increase and glucose “spills over” into the urine.. atherogenic. role of CETP and future use of CETP inhibitors. Prof. John Betteridge. University College London. United Kingdom. Diabetes and Cardiovascular Disease: Time To Act!. “With the rising tide of diabetes around the globe, the double jeopardy of diabetes and cardiovascular disease is set to result in an explosion of these and other complications- unless preventive action is taken.”. /Lipid management in . Diabetes. Dr.Zahra. . davoudi. Endocrinology department of . Loghman. Hakim Hospital, . Shahid. . Beheshti. University of Medical Sciences. A . 65 year-old woman . with medical history of . Clinics (www.dhs.state.mn.us) ProcedureRisk AssessmentThe following are examples of recommended risk factors that can be identified through the personal and family health history and physical measurem chronic metabolic disorder that prevents the body to utilize glucose completely or partially. . It is . characterised. by raised glucose in the blood and altered carbohydrate , protein and fat metabolism. . Lipidology. and Atherosclerosis (KSLA). . Hyper-LDL-. cholesterolemia. . LDL-cholesterol (LDL-. C. ) . ≥160 mg/. dL. . . or . use of lipid-lowering medication . Diabetes management in the “face of Covid-19”. . . . By . Grace . Njoku. . Lead Community Diabetes Specialist Nurse. . Learning Outcomes. Impact of Covid-19 on diabetes care.

Download Document

Here is the link to download the presentation.
"DYSLIPIDEMIA IN DIABETES"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents